UK Healthy Life Expectancy Falls to Record Low as NHS Faces Chronic Care Criticism

The Numbers Are Getting Worse, Not Better

Healthy life expectancy in the UK, meaning the years a person can expect to live free of serious illness or disability, fell to 60.7 years for men and 60.9 years for women in 2022-2024, according to the Office for National Statistics. That's down 1.8 years for men and 2.5 years for women compared with 2019-2021, and it's the lowest figure on record.

Raw life expectancy has recovered since the Covid-19 pandemic. Healthy life expectancy has not. In more than 90% of areas across England, people are now spending years of their working life, before they even hit state pension age, in poor health, according to the BBC's reporting on the ONS figures.

More working-age adults are reporting long-term conditions too. Data cited by the BBC shows 36% reported at least one chronic condition in early 2023, up from 31% in the same period of 2019. That's a five-point jump in four years, and it's happening while the country spends more on healthcare than ever before.

Patients Say Diagnosis Is Where the Help Stops

A 2025 survey from the National Voices charity found 37% of people with a long-term health condition don't feel supported by the NHS to manage their physical health. Among people with no long-term condition, that number is 16%. That's more than double the dissatisfaction rate for the people who need the system most.

Angie, a Midlands resident dealing with ME and an autoimmune thyroid condition, is one of them. She told the BBC she's spent "a fortune" on private care because the NHS couldn't deliver improvements once she was diagnosed. Her description: get the diagnosis, then you're "left to your own devices."

Angie is now preparing to relocate to Bulgaria, partly for the mountain air and community, partly because she says the healthcare there is more responsive. "You have to pay a small fee to see a doctor, but then you see one quickly," she told the BBC. She says she's "very glad" the NHS exists as a free-at-point-of-use system, but believes it's failing to deliver real health outcomes for people with chronic conditions.

A Model That Isn't Obviously Better

Bulgaria runs a hybrid system: workers, including foreign nationals, pay a compulsory 3.2% of pre-tax salary into a health insurance fund, topped up by employers, plus significant out-of-pocket costs for non-emergency visits. It's not free.

And despite that market-based structure, the OECD ranks Bulgaria's overall health outcomes relatively poorly compared with other wealthy nations. The lesson isn't that a co-pay model automatically produces better health. It's that faster access to a doctor, even a system with real financial friction, can feel like better care to a patient even if population-wide outcomes lag.

The NHS's defenders have a fair point: a system that guarantees care regardless of ability to pay is not obviously inferior just because a patient in a smaller, poorer country got a same-week appointment. Access speed and population health outcomes are two different measurements.

What the NHS Model Can't Escape

The pattern here is a government monopoly on delivery struggling with chronic, ongoing management, not acute emergencies. The NHS remains genuinely good at trauma care and emergency response. It's the long-term, unglamorous work, managing thyroid conditions, ME, autoimmune disorders over years, where patients describe being handed a diagnosis and then largely left alone.

A single-payer system with fixed budgets and no price signal has to allocate scarce specialist time somehow, and long-term chronic patients who aren't in crisis get pushed to the back of that queue. Bulgaria's co-pay model, whatever its flaws in overall outcomes, at least lets a patient pay to jump that queue.

No UK government body has announced a formal review specifically tied to the National Voices survey findings, and the ONS data itself doesn't assign blame to the NHS's structure versus underlying demographic and lifestyle factors like obesity, inactivity, or an aging population. That's a real gap. Until researchers isolate how much of the healthy-life-expectancy decline is NHS delivery versus broader public health trends, the debate over whether Britain needs a different model, not just more NHS funding, stays unresolved.